Assist Prof Dr. Vajihe Azimian Zavareh, University of Isfahan, Iran
📚 Dr. Vajihe Azimian Zavareh, Ph.D., is a dedicated researcher at Isfahan University of Medical Sciences’ Core Research Facilities laboratories. She earned her Ph.D. in Developmental Biology from the University of Tehran in 2018, focusing on Wnt signaling in ovarian cancer. Her research interests include breast and prostate cancer, 3D culture, and precision medicine. Dr. Zavareh’s expertise spans cell culture methods, PCR, flow cytometry, and immunohistochemistry. Notably, she has authored several significant publications on cancer research.
Publication Profile
Scopus
Orcid
Google Scholar
📚 Educational Background
Dr. Vajihe Azimian Zavareh completed her Ph.D. in Developmental Biology at the University of Tehran, focusing on Wnt signaling in ovarian cancer. She also holds an MSc in Animal Physiology and a BSc in Animal Biology.
💼 Work Experience
Since August 2019, Dr. Zavareh has been a Research Associate at Isfahan University of Medical Sciences. Previously, she worked at the Royan Institute for Stem Cell Biology and Technology.
Research Focus
Dr. Vajihe Azimian Zavareh’s research primarily focuses on cancer biology, particularly breast and prostate cancers. Her studies investigate the role of Wnt signaling in ovarian cancer and the impact of various treatments on cancer cell lines. Dr. Zavareh is also involved in stem cell research, exploring the therapeutic applications of mesenchymal stromal cells in conditions like rheumatoid arthritis, cirrhosis, and amyotrophic lateral sclerosis. Additionally, she works on 3D culture models to advance cancer research. Her expertise spans cell signaling, tumor microenvironment, and precision medicine. 🌿🔬📊
Publication Top Notes
- Intra-articular knee implantation of autologous bone marrow–derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized … 🌟 Cited by: 91, Year: 2018
- Intraportal Infusion of Bone Marrow Mononuclear or CD133+ Cells in Patients With Decompensated Cirrhosis: A Double-Blind Randomized Controlled Trial 🌟 Cited by: 55, Year: 2016
- Safety, feasibility of intravenous and intrathecal injection of autologous bone marrow derived mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: an open … 🌟 Cited by: 45, Year: 2019
- Mesenchymal stromal cells implantation in combination with platelet lysate product is safe for reconstruction of human long bone nonunion 🌟 Cited by: 30, Year: 2016
- Repeated intraportal injection of mesenchymal stem cells in combination with pioglitazone in patients with compensated cirrhosis: a clinical report of two cases 🌟 Cited by: 29, Year: 2016
- Effect of lithium chloride and antineoplastic drugs on survival and cell cycle of androgen-dependent prostate cancer LNCap cells 🌟 Cited by: 24, Year: 2012
- Percutaneous autologous bone marrow-derived mesenchymal stromal cell implantation is safe for reconstruction of human lower limb long bone atrophic nonunion 🌟 Cited by: 23, Year: 2017
- Combined treatment of androgen-independent prostate cancer cell line DU145 with chemotherapeutic agents and lithium chloride: Effect on growth arrest and/or apoptosis 🌟 Cited by: 23, Year: 2012
- Effect of autologous muscle‐derived cells in the treatment of urinary incontinence in female patients with intrinsic sphincter deficiency and epispadias: A prospective study 🌟 Cited by: 22, Year: 2016
- Wnt11 alters integrin and cadherin expression by ovarian cancer spheroids and inhibits tumorigenesis and metastasis 🌟 Cited by: 18, Year: 2018